ACell – PRP Case Studies

Hair Regeneration injection into balding skin of 70 year old man results in new hair growth.

ACell and PRP (platelet rich plasma) causes new terminal hair to grow

10x magnification shows new terminal hairs next to existing hairs after Hair Regeneration injection performed 3 months earlier

70 year old man injected with the new Hair Regeneration formula 3 months earlier

Note 2 things:
1) New terminal hairs sprouting all over the injected thinning area

2) The new hairs are the original dark color–NONE are gray

ACell + PRP Injection results

Patient with Severe ALOPECIA AREATA

Patient with Severe ALOPECIA AREATA – unresponsive to cotico-steroid therapy after one year and area continuing to expand. Injected with ACell/Enhanced PRP Hair Regeneration Therapy. (L) Pre-Injections, Second photo Post-Injection follow-up 7 weeks , third photo (R) 8 months post injection therapy.


ACell with PRP Injection Therapy

Above is a before (L) of a 32-year-old hair salon owner with prior hair transplantation in the temples and crown and after (R) only 3 months after ACell with PRP injection therapy.

ACell Patient Before & After Examples

Female Patient Before and After ACell/PRP

Female Before and After ACell/PRP injections – Before (L) 5/4/11 After(R) 10/10/11

Traditional Transplant vs Acell Hair Transplant


26-year-old male experiencing frontal and occipital hair loss. Patient elected to undergo ACell with saline injections (Prior to use of ACell with PRP) and postpone hair transplantation.

26-Year-Old Male Patient Before ECM+Saline Treatment

Follow up at 16 months. Patient will continue to be monitored. (No future treatments scheduled currently)

Male Case Study 1 ACell Crown

Patient Age: 29-years-old
Treatment: Acell + PRP
Condition: Progressive genetic hair loss. Patient did not want hair transplant surgery or oral treatment with Propecia.
Recommendation: Trial injections with Acell plus Platelet Rich Plasma (PRP)
Expectation: To possibly halt hair loss and evaluate in 6 months for future treatment or surgery.
Current evaluation: No further treatment until 1 year follow up.
Photos: (L) Before 7/13/10 & After (R) 1/18/11

Acell + PRP Injections B&A

Patient Age: 52
Treatment: Acell + PRP
Condition: Class VI genetic hair loss pattern. Patient had previous hair transplant surgery with poor growth
Recommendation: Trial injections with Acell plus Arterial Platelet Rich Plasma (APRP)
Expectation: To possibly halt additional hair loss and thicken existing hair transplants
Current Evaluation: At 1 Year follow-up there is additional hair growth from the surrounding hair and from previous hair transplants. No apparent ongoing hair loss.
Photos: Before (L) 1/16/10, After (R) 1/15/11

52-Year-Old Male Patient Before and After Treatment


ACell’s patented Extracellular Matrix (ECM) products are covered by multiple 510(k) clearances and address important unmet clinical needs, providing safe, effective and therapeutic outcomes. Derived from porcine urinary bladders and referred to as UBM (urinary bladder matrix), trademarked as MatriStem™, ACell’s core technology is a naturally occurring, non-crosslinked, completely resorbable acellular biomaterial. A similar “first generation” ECM technology has been used to treat over 500,000 patients with remarkable effect. ACell’s MatriStem products are the next generation of ECM technology due to its unique characteristics featuring a basement membrane surface which is ideal for epithelial cell growth in many applications.

Scarring in Hair Transplant Area from Other Hair Transplant Center Before Hair Regeneration Treatment

Scarring in old hair transplant donor areas before ACell treatment

New Hair Regrowth and Better Healing

New hair growth in donor scar 4 months later.

Female patient before Acell

Female patient before

Female patient after Acell

After 3 months post op grafts dipped in ACELL prior to transplanting

Female patient before Acell PRP

Female patient before

Female patient after Acell PRP

After 3 months post op grafts dipped in ACELL prior to transplanting

Female patient before transplant

Female patient before

Female patient after transplant

After 6 months post op grafts dipped in ACELL prior to transplanting

ACell’s technology is not limited to one market segment (e.g., wound care), but instead can serve as a core technology for treatments across a broad range of human medical conditions. For more information go to: www.acell.com